|
"llovet josep m"的相關文件
顯示項目 1-2 / 2 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-03-02T14:00:13Z |
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
|
Zhu, Andrew X.; Finn, Richard S.; Kang, Yoon Koo; Yen, Chia Jui; Galle, Peter R.; Llovet, Josep M.; Assenat, Eric; Brandi, Giovanni; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Vogel, Arndt; Yamashita, Tatsuya; CHIH-HUNG HSU; Gerken, Guido; Bilbruck, John; Hsu, Yanzhi; Liang, Kun; Widau, Ryan C.; Wang, Chunxiao; Abada, Paolo; Kudo, Masatoshi |
| 國立成功大學 |
2016-10 |
Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC)
|
Llovet, Josep M.;Merle, Philippe;Weiss, Karl Heinz;Yau, Thomas;Ross, Paul;Mazzaferro, Vincenzo;Blanc, Jean-Frederic;Ma, Yuk T.;Yen, Chia Jui;Kocsis, Judit;Choo, Su Pin;Sukeepaisarnjaroen, Watana;Gerolami, Rene;Dufour, Jean -Francois;Gane, Edward J.;Ryoo, Baek-Yeol;Peck-Radosavljevic, Markus;Dao, Thong;Yeo, Winnie;Lamlertthon, Wisut;Thongsawat, Satawat;Teufel, Michael;Krissel, Heiko;Lim, Ho Yeong |
顯示項目 1-2 / 2 (共1頁)
1
每頁顯示[10|25|50]項目
|
